Company page

Nuvectis Pharma, Inc.

Nuvectis Pharma, Inc. is a public company traded under the ticker NVCT in the American market. The company has a market capitalization of approximately $608.76 million. Nuvectis focuses on developing innovative therapies for cancer treatment.

NVCT:NASDAQUpdated September 11, 2026
Nuvectis Pharma, Inc. logo
Ticker
NVCT:NASDAQ
Asset type
Stock
Market cap
$783.1M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD